Published in Law and Health Weekly, September 6th, 2008
Dr. Tapolsky brings over 20 years of experience in corporate management, research and pharmaceutical development to ACT. In this newly created position, he will be responsible for the leadership of all pre-clinical and clinical development activities.
"We are thrilled to have Gilles join our team. He has led a distinguished career in pharmaceutical development and is recognized as a leader in the biotechnology field," said Randall B. Riggs, president & chief executive officer at ACT. "With his track record of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.